61 – 70 of 310
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Study protocol of the InterVitaminK trial : A Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health
- Contribution to journal › Article
-
Mark
Association between self-reported alcohol consumption and diastolic dysfunction : a cross-sectional study
- Contribution to journal › Article
-
Mark
Use of healthcare before and after sepsis in Sweden : a case-control study
- Contribution to journal › Article
-
Mark
Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries : a pragmatic cluster randomised trial protocol
- Contribution to journal › Article
-
Mark
Facilitators and barriers impacting in-hospital Trauma Quality Improvement Program (TQIP) implementation across country income levels a scoping review
- Contribution to journal › Scientific review
-
Mark
Protocolised reduction of non-resuscitation fluids versus usual care in patients with septic shock (REDUSE) : a protocol for a multicentre feasibility trial
- Contribution to journal › Article
-
Mark
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers
- Contribution to journal › Article
-
Mark
Association between attending cultural events and all-cause mortality : a longitudinal study with three measurements (1982–2017)
- Contribution to journal › Article
-
Mark
Exploring nurses' experiences of a tailored intervention to increase MMR vaccine acceptance in a Somali community in Stockholm, Sweden : a qualitative interview study
- Contribution to journal › Article
-
Mark
Inhaled ciclesonide in adults hospitalised with COVID-19 : a randomised controlled open-label trial (HALT COVID-19)
- Contribution to journal › Article
